<SEC-DOCUMENT>0001976408-23-000005-index.html : 20230516
<SEC-HEADER>0001976408-23-000005.hdr.sgml : 20230516
<ACCEPTANCE-DATETIME>20230516173634
ACCESSION NUMBER:		0001976408-23-000005
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20230516
DATE AS OF CHANGE:		20230516

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Viking Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001607678
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				461073877
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-37355
		FILM NUMBER:		23928888

	BUSINESS ADDRESS:	
		STREET 1:		9920 PACIFIC HEIGHTS BLVD, SUITE 350
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-704-4660

	MAIL ADDRESS:	
		STREET 1:		9920 PACIFIC HEIGHTS BLVD, SUITE 350
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Rowland Charles A Jr
		CENTRAL INDEX KEY:			0001383292

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		3338 LANCASHIRE RD
		CITY:			FURLONG
		STATE:			PA
		ZIP:			18925
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>